AnticoagEvaluator

Version 5.0
Update Time October 2, 2025
Category Sports and Health
Size 5.05MB

About this app

Make informed anti thrombotic therapy decisions for AF patients.

Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.

Use the app to:

• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed

• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention

• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.

• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.

This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com

What's New in the Latest Version 5.0

Last updated on Dec 12, 2024 This app has been updated with an enhanced Risk Bar which showcases CHA2DS2-VASc and ATRIA stroke risk point scores for all patients alongside the stroke risk magnitude percentage. In addition, a visual display bug was fixed and standard notification functionality was incorporated.

Screenshots